Please wait while the formulary information is being retrieved.
CLEOCIN (CLINDAMYCIN PHOSPHATE)
- Bacterial vaginosis
clindamycin 2 % vaginal cream
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime
100 mg vaginal suppository
- Insert 1 suppository (100 mg) by vaginal route once daily at bedtime for 3 days
2 % vaginal cream
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime
Bacterial vaginosis
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime for 3 days
- Insert 1 applicatorful (100 mg) by vaginal route once daily at bedtime for 7 days
- Insert 1 suppository (100 mg) by vaginal route once daily at bedtime for 3 days
- typhoid vaccine
- Vivotif Berna Vaccine
Contraindicated
- None
Severe
Moderate
- None
- Crohn's disease
- Ulcerative colitis
Contraindicated
- Clostridium difficile infection
Severe
Moderate
- None
CLEOCIN (CLINDAMYCIN PHOSPHATE)
- Bacterial vaginosis
- Genital organ pruritus
- Vaginitis
- Vulvovaginal candidiasis
More Frequent
Severe
Less Severe
- Abdominal pain with cramps
- Headache disorder
- Nausea
- Vomiting
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Candidiasis
- Clostridium difficile infection
- Diarrhea
- Edema
Less Severe
- Abnormal vaginal bleeding
- Constipation
- Dizziness
- Dysgeusia
- Dyspepsia
- Dysuria
- Epistaxis
- Erythema
- Flatulence
- Halitosis
- Hyperthyroidism
- Menstrual disorder
- Skin rash
- Upper respiratory infection
- Urinary tract infection
- Urticaria
- Vaginal discharge
- Vertigo
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Clindamycin (vaginal)
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Clindamycin (top, Vag)
- Severity Level:
2
- Additional Notes: Insuff human and animal data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Clindamycin (top, Vag)
Avoiding nipple area application will reduce infants risk for diarrhea
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Avoiding nipple area application will reduce infants risk for diarrhea |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Bacterial vaginosis | |
| N76.0 | Acute vaginitis |
| 0-9 | A-Z |
|---|---|
| N76.0 | Acute vaginitis |
Formulary Reference Tool